Department of Urology, Nihon University School of Medicine, Tokyo, Japan.
J Int Med Res. 2022 Jun;50(6):3000605221106434. doi: 10.1177/03000605221106434.
We aimed to evaluate the mid-term efficacy of tension-free vaginal mesh (TVM) for pelvic organ prolapse (POP), and observe the time course of lower urinary tract symptoms and sexual function.
In this retrospective study, we included 112 female patients who underwent TVM at a single center for stage 2 or higher POP, and replied to questionnaires before, and 2 and 4 years after TVM. We evaluated the anatomical cure rate, prolapse quality of life questionnaire scores, international prostate symptom scores, International Consultation on Incontinence Questionnaire-Short Form scores, and Female Sexual Function Index scores.
The anatomical cure rate at 4 years was 89%. Voiding and storage symptoms improved in patients after TVM. We found that 25/112 patients had sexual intercourse before TVM, and among them, 15/25 (60%) continued sexual intercourse after TVM. Additionally, of the 87 patients who had no sexual intercourse before TVM, 13 resumed sexual intercourse after TVM.
Cases of TVM have decreased because of the Food and Drug Administration statements concerning mesh problems. However, this study showed relatively favorable mid-term results for lower urinary tract symptoms. Furthermore, sexual activity was restored in some patients, indicating the efficacy of TVM for sexual function.
评估经阴道无张力网片(TVM)治疗盆腔器官脱垂(POP)的中期疗效,并观察下尿路症状和性功能的时间变化。
在这项回顾性研究中,我们纳入了在单中心因 2 期或更高期 POP 接受 TVM 的 112 名女性患者,她们在 TVM 前、后 2 年和 4 年均回复了问卷。我们评估了解剖学治愈率、脱垂生活质量问卷评分、国际前列腺症状评分、国际尿失禁咨询问卷-短表评分和女性性功能指数评分。
4 年后的解剖学治愈率为 89%。TVM 后,排尿和储尿症状得到改善。我们发现,112 名患者中有 25 名有性生活,其中 15/25(60%)在 TVM 后继续有性生活。此外,在 87 名 TVM 前没有性生活的患者中,有 13 名在 TVM 后恢复了性生活。
由于食品和药物管理局对网片问题的声明,TVM 的病例有所减少。然而,本研究显示 TVM 对下尿路症状具有较好的中期疗效。此外,一些患者恢复了性生活,表明 TVM 对性功能有效。